abstract |
2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5 Pediatric formulations comprising the methanesulfonate salt of triazin-2-yl)amino]propan-2-ol and methods for treating, preventing and managing cancer using the same are herein described. Presented. |